AVCNF
Price
$0.18
Change
-$0.01 (-5.26%)
Updated
Jun 13 closing price
Capitalization
18.52M
BSPK
Price
$0.12
Change
+$0.02 (+20.00%)
Updated
Jun 12 closing price
Capitalization
1.53M
Interact to see
Advertisement

AVCNF vs BSPK

Header iconAVCNF vs BSPK Comparison
Open Charts AVCNF vs BSPKBanner chart's image
Avicanna
Price$0.18
Change-$0.01 (-5.26%)
Volume$25.36K
Capitalization18.52M
Bespoke Extracts
Price$0.12
Change+$0.02 (+20.00%)
Volume$405
Capitalization1.53M
AVCNF vs BSPK Comparison Chart
Loading...
View a ticker or compare two or three
VS
AVCNF vs. BSPK commentary
Jun 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AVCNF is a Hold and BSPK is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 14, 2025
Stock price -- (AVCNF: $0.18 vs. BSPK: $0.12)
Brand notoriety: AVCNF and BSPK are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: AVCNF: 59% vs. BSPK: 27%
Market capitalization -- AVCNF: $18.52M vs. BSPK: $1.53M
AVCNF [@Pharmaceuticals: Other] is valued at $18.52M. BSPK’s [@Pharmaceuticals: Other] market capitalization is $1.53M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.78B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AVCNF’s FA Score shows that 0 FA rating(s) are green whileBSPK’s FA Score has 0 green FA rating(s).

  • AVCNF’s FA Score: 0 green, 5 red.
  • BSPK’s FA Score: 0 green, 5 red.
According to our system of comparison, BSPK is a better buy in the long-term than AVCNF.

Price Growth

AVCNF (@Pharmaceuticals: Other) experienced а +5.69% price change this week, while BSPK (@Pharmaceuticals: Other) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -0.42%. For the same industry, the average monthly price growth was +14.50%, and the average quarterly price growth was +67.02%.

Reported Earning Dates

BSPK is expected to report earnings on Apr 21, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (-0.42% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

FUNDAMENTALS
Fundamentals
AVCNF($18.5M) has a higher market cap than BSPK($1.53M). BSPK YTD gains are higher at: 89.145 vs. AVCNF (-13.011). BSPK has higher annual earnings (EBITDA): -828.97K vs. AVCNF (-13.98M). AVCNF has more cash in the bank: 222K vs. BSPK (10.9K). BSPK has less debt than AVCNF: BSPK (456K) vs AVCNF (1.81M). AVCNF has higher revenues than BSPK: AVCNF (4.18M) vs BSPK (31.8K).
AVCNFBSPKAVCNF / BSPK
Capitalization18.5M1.53M1,209%
EBITDA-13.98M-828.97K1,687%
Gain YTD-13.01189.145-15%
P/E RatioN/AN/A-
Revenue4.18M31.8K13,145%
Total Cash222K10.9K2,037%
Total Debt1.81M456K396%
FUNDAMENTALS RATINGS
BSPK: Fundamental Ratings
BSPK
OUTLOOK RATING
1..100
93
VALUATION
overvalued / fair valued / undervalued
1..100
93
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
37
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
RSI
ODDS (%)
Stochastic
ODDS (%)
Momentum
ODDS (%)
MACD
ODDS (%)
TrendWeek
ODDS (%)
TrendMonth
ODDS (%)
Advances
ODDS (%)
Declines
ODDS (%)
BollingerBands
ODDS (%)
Aroon
ODDS (%)
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
NAC11.030.03
+0.30%
Nuveen California Quality Municipal Income Fund
MDEV20.29N/A
N/A
First Trust Indxx Global Mdcl Dvcs ETF
IGA9.99-0.05
-0.50%
Voya Global Advantage AND Premium Opportunity Fund
FLMX30.11-0.22
-0.72%
Franklin FTSE Mexico ETF
GXC86.88-1.46
-1.65%
SPDR® S&P China ETF

AVCNF and

Correlation & Price change

A.I.dvisor tells us that AVCNF and PRFX have been poorly correlated (+20% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that AVCNF and PRFX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AVCNF
1D Price
Change %
AVCNF100%
-8.17%
PRFX - AVCNF
20%
Poorly correlated
-5.58%
ARSUF - AVCNF
12%
Poorly correlated
N/A
BSPK - AVCNF
9%
Poorly correlated
N/A
APNHY - AVCNF
7%
Poorly correlated
-2.03%
BKUH - AVCNF
5%
Poorly correlated
N/A
More

BSPK and

Correlation & Price change

A.I.dvisor tells us that BSPK and AVCNF have been poorly correlated (+9% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BSPK and AVCNF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BSPK
1D Price
Change %
BSPK100%
N/A
AVCNF - BSPK
9%
Poorly correlated
-8.17%
CHSYF - BSPK
9%
Poorly correlated
N/A
CAIHF - BSPK
4%
Poorly correlated
N/A
BOIRF - BSPK
4%
Poorly correlated
N/A
ARSUF - BSPK
2%
Poorly correlated
N/A
More